BME100 f2015:Group12 1030amL1

BME 100 Fall 2015	Home People Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3 Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6 Course Logistics For Instructors Photos Wiki Editing Help
OUR TEAM Name: Cory Kehoe Name: Pedro Lopes Name: Daniel Gaytan-Jenkins Name: Brittany Metzler Name: Morgan Baerwaldt Name: Jaxon Lewandowski LAB 1 WRITE-UP Independent and Dependent Variables Independent variable: lipopolysaccharide Dependent variable: inflammatory protein (Inflammotin) Controlled items: Same dosage over trial period for one subject Administered at same time of day Consistent diet Testing done on same day every week Experimental Design Length of test: until the maximum expression of the protein is reached Weekly checkins Checkin 1: take blood sample using ELISA and provide first dosage Future checkins: continue to take blood samples using ELISA and provided continued dosages Groups - (72 people total) Control group: sugar pill (placebo) 10 mg pill of lipopolysaccharide 8 mg pill of lipopolysaccharide 6 mg pill of lipopolysaccharide 4 mg pill of lipopolysaccharide 2 mg pill of lipopolysaccharide Age Retirement age: 65-85 - 88% of nursing home residents are 65 or older, and 45% are 85 or older. - Statistic from a report done by AARP - http://assets.aarp.org/rgcenter/il/fs10r_homes.pdf Number of subjects per group 12 subjects per group Subject Selection Random selection in retirement homes and communities based off of their room numbers and addresses Must fit the following criteria: health standards ambulatory able to give informed consent close to equal amount of men and women Sources of Error and Bias Individual’s reaction to drug review preexisting health conditions to determine if participants are eligible for the study Location of subjects’ residences (the demographic) Deaths not related to the study